Literature DB >> 20585763

Clinical safety of magnetic resonance imaging in patients with implanted SynchroMed EL infusion pumps.

Felix E Diehn1, Christopher P Wood, Robert E Watson, William D Mauck, Michelle M Burke, Christopher H Hunt.   

Abstract

INTRODUCTION: Patients with implanted SynchroMed spinal infusion pumps (Medtronic, Inc., Minneapolis, MN) routinely undergo magnetic resonance imaging at our institution. In August 2008, Medtronic issued an urgent medical device correction report regarding several pumps. Because of the rare potential "for a delay in the return of proper drug infusion" and "for a delay in the logging of motor stall events," "a patient's pump must be interrogated after MRI exposure in order to confirm proper pump functionality." This is particularly important in patients receiving intrathecal baclofen, for whom a delay in return of proper pump infusion could lead to life-threatening baclofen withdrawal syndrome. The objective of this report is to present our experience and protocol of performing magnetic resonance imaging in patients with implanted SynchroMed EL pumps.
METHODS: We retrospectively reviewed records of 86 patients with implanted SynchroMed EL spinal infusion pumps who underwent 112 examinations on 1.5-T magnetic resonance imaging scanners from September 1, 1998 to July 7, 2004.
RESULTS: No SynchroMed EL pumps were damaged by magnetic resonance imaging, and the programmable settings remained unchanged in all patients.
CONCLUSIONS: Our data suggest that SynchroMed EL pump malfunction is indeed rare after routine clinical 1.5-T magnetic resonance imaging examinations. However, based on the Medtronic correction report, we perform pump interrogation before and after imaging.

Entities:  

Mesh:

Year:  2010        PMID: 20585763     DOI: 10.1007/s00234-010-0737-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  16 in total

Review 1.  Intrathecal drug therapy for chronic pain: from basic science to clinical practice.

Authors:  P M Dougherty; P S Staats
Journal:  Anesthesiology       Date:  1999-12       Impact factor: 7.892

2.  MRI compatibility and visibility assessment of implantable medical devices.

Authors:  B A Schueler; T B Parrish; J C Lin; B E Hammer; B J Pangrle; E R Ritenour; J Kucharczyk; C L Truwit
Journal:  J Magn Reson Imaging       Date:  1999-04       Impact factor: 4.813

Review 3.  MRI safety review.

Authors:  Mary F Dempsey; Barrie Condon; Donald M Hadley
Journal:  Semin Ultrasound CT MR       Date:  2002-10       Impact factor: 1.875

4.  Safety of active implantable devices during MRI examinations: a finite element analysis of an implantable pump.

Authors:  Philippe Büchler; Anne Simon; Jürgen Burger; Alec Ginggen; Rocco Crivelli; Yanik Tardy; Roger Luechinger; Sigbjørn Olsen
Journal:  IEEE Trans Biomed Eng       Date:  2007-04       Impact factor: 4.538

5.  MR imaging of patients with implanted drug infusion pumps.

Authors:  R von Roemeling; R M Lanning; F A Eames
Journal:  J Magn Reson Imaging       Date:  1991 Jan-Feb       Impact factor: 4.813

Review 6.  Therapeutic applications of implantable drug delivery systems.

Authors:  A K Dash; G C Cudworth
Journal:  J Pharmacol Toxicol Methods       Date:  1998-07       Impact factor: 1.950

7.  Complications of neuraxial infusion in cancer patients.

Authors:  S Du Pen
Journal:  Oncology (Williston Park)       Date:  1999-05       Impact factor: 2.990

Review 8.  Practical issues when using neuraxial infusion.

Authors:  E S Krames
Journal:  Oncology (Williston Park)       Date:  1999-05       Impact factor: 2.990

9.  Intrathecal baclofen for severe spinal spasticity.

Authors:  R D Penn; S M Savoy; D Corcos; M Latash; G Gottlieb; B Parke; J S Kroin
Journal:  N Engl J Med       Date:  1989-06-08       Impact factor: 91.245

10.  Intrathecal opioid therapy for pain: efficacy and outcomes.

Authors:  W Winkelmüller; K Burchiel; J P Van Buyten
Journal:  Neuromodulation       Date:  1999-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.